Characteristics | Breakdown of Factors | Age Group ≤ 45 years N = 64 | Age Group > 45 years N = 65 | p value |
Age (years) Median (IQR) |
| 36 years (27, 41) | 56 years (50, 60) | <0.001 |
FIGO Stage N (%) | Stage I Stage II Stage III Stage IV | 20 (31.2%) 3 (4.7%) 32 (50.0%) 9 (14.1%) | 10 (15.4%) 6 (9.2%) 39 (60.0%) 10 (15.4%) | 0.167 |
CA125 at diagnosis N (%) | ≤200 >200 | 10 (26.3%) 28 (73.7%) | 2 (5.9%) 32 (94.1%) | 0.044 |
Age of menarche (years), median (IQR) |
| 12 (12, 13) | 12 (12, 13) | 0.935 |
Age of menopause (years), median (IQR) |
| 41 (40, 45) | 50 (45, 52) | <0.001 |
Menopausal n (%) |
| 16 (25%) | 64 (98.46%) | <0.001 |
Timing of surgery—Days from diagnosis for PDS & staging Days from last chemo for IDS | *PDS *IDS Staging laparotomy | 18 (28.1%) 22 (34.4%) 24 (37.5%) | 20 (30.8%) 26 (40.0%) 19 (29.2%) | 0.603 |
Follow-up (months, median (IQR) |
| 12 (6, 42) | 6 (3, 18) | 0.016) |
Interval between diagnosis and surgery (days), median (IQR) |
| 46.50 (28, 94.75) | 52 (27, 92) | 0.815 |
Survival N (%) | Alive Dead of Disease | 27 (43.5%) 35 (56.5% | 12 (20.0%) 48 (80%) | 0.005 |
Histopathology N (%) | Serous Mucinous Other | 48 (75%) 11 (17.2%) 5 (7.8%) | 54 (83.1%) 2 (3.1%) 9 (13.8%) | 0.021 |